Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHEK1 | O14757 | 1/20 | 0.38 |
| ▸ | WEE1 | P30291 | 1/20 | 0.38 |
| ▸ | KAT2B | Q92831 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | PRKACA | P17612 | 1/20 | 0.37 |
| ▸ | PRKACG | P22612 | 1/20 | 0.37 |
| ▸ | PRKACB | P22694 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | GNRHR | P30968 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28641642 | 0.89 | KDM4E (0.45) | KDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL21900258 | 0.86 | APEX1 (0.42) | CHEK1WEE1KDM4EALDH1A1CYP3A4 | |
| SCHEMBL19873696 | 0.82 | KDM4E (0.44) | CHEK1WEE1KAT2BKDM4EALDH1A1 | |
| SCHEMBL17870801 | 0.80 | IDO1 (0.33) | SMN1; SMN2 | |
| SCHEMBL19873965 | 0.80 | JAK3 (0.37) | KDM4EALDH1A1SMN1; SMN2GNRHR | |
| SCHEMBL17870711 | 0.80 | IDO1 (0.43) | — | |
| SCHEMBL30178581 | 0.80 | CCNE2 (0.34) | KDM4EALDH1A1SMN1; SMN2GNRHR | |
| SCHEMBL21900230 | 0.79 | FPR1 (0.41) | KDM4E | |
| SCHEMBL17870754 | 0.79 | CCNE2 (0.33) | CYP3A4GNRHR | |
| SCHEMBL19873988 | 0.77 | APAF1 (0.36) | CYP3A4GNRHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3708566-B1 | NOVEL HETEROCYCLIC COMPOUNDS AND THE USE THEREOF IN MEDICINE AND IN COSMETICS | GALDERMA RES & DEV (FR) | 2023-02-08 | — | — | EP | disclosed |
| CN-107428744-B | Novel heterocyclic compounds and their use in medicine and cosmetics | 盖尔德马研究及发展公司 | 2021-09-24 | — | — | CN | disclosed |